Clinical benefits of pegylated proteins in oncology

被引：10

作者：

Crawford, J

机构：

来源：

CANCER TREATMENT REVIEWS | 2002年 / 28卷

关键词：

D O I：

10.1016/S0305-7372(02)80001-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 2

页数：2

共 7 条

[1] Polyethylene glycol-conjugated pharmaceutical proteins [J].

Bailon, P ;

Berthold, W .

PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :352-356

[2] Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy [J].

Johnston, E ;

Crawford, J ;

Blackwell, S ;

Bjurstrom, T ;

Lockbaum, P ;

Roskos, L ;

Yang, BB ;

Gardner, S ;

Miller-Messana, MA ;

Shoemaker, D ;

Garst, J ;

Schwab, G .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2522-2528

[3] Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma:: a study by the EORTC Soft Tissue and Bone Sarcoma Group [J].

Judson, I ;

Radford, JA ;

Harris, M ;

Blay, JY ;

van Hoesel, Q ;

le Cesne, A ;

van Oosterom, AT ;

Clemons, MJ ;

Kamby, C ;

Hermans, C ;

Whittaker, J ;

di Paola, ED ;

Verweij, J ;

Nielsen, S .

EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) :870-877

[4] Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C [J].

Kozlowski, A ;

Harris, JM .

JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) :217-224

[5]

Motzer R, 2001, P AN M AM SOC CLIN, V20, p180a

[6] Doxorubicin encapsulated in liposomes containing surface-found polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma [J].

Northfelt, DW ;

Martin, FJ ;

Working, P ;

Volberding, PA ;

Russell, J ;

Newman, M ;

Amantea, MA ;

Kaplan, LD .

JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (01) :55-63

[7] Controlled-release, pegylation, liposomal formulations: New mechanisms in the delivery of injectable drugs [J].

Reddy, KR .

ANNALS OF PHARMACOTHERAPY, 2000, 34 (7-8) :915-923

← 1 →